References

Gorski LA, Hadaway L, Hagle ME Infusion therapy standards of practice. J Infus Nurs. 2021; 44:(1S)S1-S224 https://doi.org/10.1097/NAN.0000000000000396

Hugill K. Vascular access in neonatal care settings: selecting the appropriate device. Brit J Nur. 2016; 25:(3)171-176 https://doi.org/10.12968/bjon.2016.25.3.171

Legemaat M, Carr PJ, van Rens RM, VanDijk M, Poslawsky IE, van den Hoogen A. Peripheral intravenous cannulation: complication rates in the neonatal population: a multicenter observational study. J Vasc Access. 2016; 17:(4)360-365 https://doi.org/10.5301/jva.5000558

Chenoweth KB, Guo J-W, Chan B. The extended dwell peripheral intravenous catheter is an alternative method of NICU intravenous access. Adv Neonatal Care. 2018; 18:(4)295-301 https://doi.org/10.1097/ANC.0000000000000515

Unbeck M, Förberg U, Ygge B-M, Ehrenberg A, Petzold M, Johansson E. Peripheral venous catheter related complications are common among paediatric and neonatal patients. Acta Paediatr. 2015; 104:(6)566-574 https://doi.org/10.1111/apa.12963

Danski MTR, Mingorance P, Johann DA, Vayego SA, Lind J. Incidence of local complications and risk factors associated with peripheral intravenous catheter in neonates. Rev Esc Enferm USP. 2016; 50:(1)22-28 https://doi.org/10.1590/S0080-623420160000100003

Indarwati F, Mathew S, Munday J, Keogh S. Incidence of peripheral intravenous catheter failure and complications in paediatric patients: systematic review and meta analysis. Int J Nurs Stud. 2020; 102 https://doi.org/10.1016/J.IJNURSTU.2019.103488

Monasor-Ortolá D, Cortés-Castell E, Martínez-Pascual C, Esteve-Ríos A, Rizo-Baeza MM. Factors influencing the success of peripheral venous access in neonates. J Pediatr Nurs. 2019; 47:e30-e35 https://doi.org/10.1016/j.pedn.2019.04.017

Atay S, Sen S, Cukurlu D. Incidence of infiltration/extravasation in newborns using peripheral venous catheter and affecting factors. Rev Esc Enferm USP. 2018; 52 https://doi.org/10.1590/S1980-220X2017040103360

Odom B, Lowe L, Yates C. Peripheral infiltration and extravasation injury methodology: a retrospective study. J Infus Nurs. 2018; 41:(4)247-252 https://doi.org/10.1097/NAN.0000000000000287

Murphy AD, Gilmour RF, Coombes CJ. Extravasation injury in a pediatric population. ANZ J Surg. 2019; 89:(4)E122-E126 https://doi.org/10.1111/ANS.14104

Corbett M, Marshall D, Harden M, Oddie S, Phillips R, McGuire W. Treatment of extravasation injuries in infants and young children: a scoping review and survey. Health Technol Assess. 2018; 22:(46)1-112 https://doi.org/10.3310/hta22460

Doellman D, Hadaway L. Bowe-Geddes LA. Infiltration and extravasation: update on prevention and management. J Infusion Nurs. 2009; 32:(4)203-211

Tofani B, Rineair S, Gosdin CH Quality improvement project to reduce infiltration and extravasation events in a pediatric hospital. J Pediatri Nurs. 2012; 27:(6)682-689 https://doi.org/10.1016/j.pedn.2012.01.005

Boyar V, Galiczewski C, Kurepa D. Point-of-care ultrasound use in neonatal peripheral intravenous extravasation injuries. J Wound, Ostomy Continence Nurs. 2018; 45:(6)503-509 https://doi.org/10.1097/WON.0000000000000475

Girish KS, Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sciences. 2007; 80:1921-1943

Jung H. Hyaluronidase: an overview of its properties, applications, and side effects. Arch Plast Surg. 2020; 47:297-300

Paap MK, Silkiss RZ. The interaction between hyaluronidase and hyaluronic acid gel fillers—a review of the literature and comparative analysis. Plast Aesthet Res. 2020; 7 https://doi.org/10.20517/2347-9264.2020.121

Yan YM, Fan QL, Li AQ, Chen JL, Dong FF, Gong M. Treatment of cutaneous injuries of neonates induced by drug extravasation with Hyaluronidase and Hirudoid. Iran J Pediatr. 2014; 24:(4)352-358

Hugill K, Van Rens M. Inserting central lines via the peripheral circulation in neonates. Brit J Nurs. 2020; 29:(19)S12-S18 https://doi.org/10.12968/bjon.2020.29.19.S12

Electronic Medicines Compendium, (emc). Glucose 10% w/v solution for infusion. https://www.medicines.org.uk/emc/product/1823/smpc (Accessed March 28, 2021)

van Rens M, Hugill K, Francia AV. A new approach for early recognition of peripheral intravenous (PIV) infiltration: a pilot appraisal of a sensor technology in a neonatal population. Vascular Access. 2019; 5:(2)38-41 https://doi.org/10.33235/va.5.2.38-41

Treatment of a neonatal peripheral intravenous infiltration/extravasation (PIVIE) injury with hyaluronidase: a case report

21 April 2022
6 min read
Volume 31 · Issue 8

Abstract

Introduction:

Intravenous therapy-related injury, its prevention, and treatment are ubiquitous topics of interest among neonatal clinicians and practitioners. This is due to the economic costs, reputational censure, and patents' wellbeing concerns coupled with the possibility of potentially avoidable serious and life-long harm occurring in this vulnerable patient population.

Case description:

A term infant receiving a hypertonic dextrose infusion for the management of hypoglycemia developed a fulminating extravasation shortly after commencement of the infusion. This complication developed without notification of infusion pump pressure changes pertaining to a change in blood vessel compliance or early warning of infiltration by the optical sensor site monitoring technology (ivWatch®) in use. The injury was extensive and treated with a hyaluronidase/saline mix subcutaneously injected into the extravasation site using established techniques. Over a period of 2 weeks, the initially deep wound healed successfully without further incident, and the infant was discharged home without evident cosmetic scarring or functional effects.

Conclusion:

This article reports on a case of a term baby who postroutine insertion of a peripherally intravenous catheter showed an extreme reaction to extravasation of the administered intravenous fluids. We discuss the condition, our successful management with hyaluronidase, and the need to remain observationally vigilant of intravenous infusions despite the advances in infusion monitoring technology.

HIGHLIGHTS

In a neonatal population peripheral infusion therapy-related complication rates have been reported to be as high as 75%

Peripheral IV infiltration and extravasation (PIVIE) is implicated in up to 65% of IV-related complications

PIVIE injury has the potential to cause serious harm

Prompt recognition and timely appropriate intervention can mitigate many of these risks

Adhering to the 5Rs for vascular access optimizes infusion therapy and potentially reduces complications

Ensuring safe vascular access for the delivery of intravenous (IV) therapies is a cornerstone of everyday neonatal practice.1,2 IV access is obtained via peripheral and central veins with peripheral vein cannulation being the most frequently performed procedure in the Neonatal Intensive Care Unit (NICU).3,4 However, obtaining and maintaining IV access in the neonatal patient population is often challenging and can be a common cause of iatrogenic complication and injury.5

While many complications are minor, the risk of peripheral IV infiltration and extravasation (PIVIE) injury has the potential to cause more serious harm. The reported risk of a peripheral IV-related complication in this patient population is variable with some authors of single and multicenter studies reporting complication rates of 63.5% to 75%.3,56 Pooled figures for extravasation incidence from meta-analyses also show considerable heterogeneity.7 In part, this variation is due to differing classifications of what constitutes a complication, definitional overlap, and amalgamation of complication incidence in reported figures (eg infiltration, extravasation, and leakage reported together). Furthermore, various confounding factors such as weight, gestational age, the nature of the infusion fluid, the use of vascular access technology to evaluate potential insertion sites, chosen vein, underlying pathology, and practitioner skill all influence risk.2,8 According to several sources, PIVIE is implicated in 65% of neonatal IV complications.3,9,10,11 Because of this high prevalence, numerous evidence-based measures have been implemented to reduce the likelihood and severity of complications. These interventions include care bundles, site selection, and evaluation tools (eg VeinViewer© [Christies], and the touch, look, compare mnemonic), catheter design and material innovations, dynamic inline occlusion pressure monitoring, and insertion site optical monitoring technology (eg ivWatch®). In the neonatal literature, treatment of PIVIE is underreported.12 In the case we describe, we discuss our current practice in the treatment of PIVIE.

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content